Rinkey Investments’s Lunai Bioworks LNAI Stock Holding History

Rinkey Investments’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-13	Closed	-$6K	–	196
2021 Q4	$6K	Buy	+13	New	+$9.44K	0.01%	179

Other funds holding LNAI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rinkey Investments's LNAI Position: Q1 2022 in Review

Rinkey Investments sold out of Lunai Bioworks (LNAI) in Q1 2022, closing a stake of 13 shares — an estimated $6K sold.

Rinkey Investments first reported a position in LNAI in Q4 2021 and held it in 1 quarter. The position peaked at $6K in Q4 2021. 43 funds tracked by Wall St. Rank hold LNAI as of Q1 2022.

Rinkey Investments reported no remaining Lunai Bioworks position as of Q1 2022 after selling out during the quarter.
Rinkey Investments sold 13 Lunai Bioworks shares in Q1 2022, an estimated $6K.
Rinkey Investments first reported a position in Lunai Bioworks in Q4 2021 and held it in 1 quarter.
Rinkey Investments's Lunai Bioworks position peaked at $6K in Q4 2021.
43 funds tracked by Wall St. Rank held Lunai Bioworks as of Q1 2022.

Based on Rinkey Investments's 13F filing for Q1 2022, filed 9 May 2022.